Biotech NewsAxsome (AXSM) Posts $150M Q2 Revenue, Beats EPS Expectations BioTech Health XSeptember 5, 2025 Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a biopharmaceutical company headquartered in New York City that is focused on… 0 Shares 0 0 0 0 0 0 0